Annual Report 2024-25 alongwith Notice of 44th AGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Denis Chem Lab Limited, a Gujarat-based manufacturer of parenteral pharmaceutical products, has filed the notice for its 44th Annual General Meeting scheduled for 26th September 2025 at 12:00 noon via video conferencing, along with the Annual Report for FY2024-25. The AGM will consider adoption of audited financial statements for the year ended 31st March 2025 and declaration of a final dividend of Rs. 1.50 per equity share on face value of Rs. 10. Other items include re-appointment of Mr. Dinesh B. Patel (Chairman) who retires by rotation, approval of Rs. 1,70,000 remuneration for Cost Auditors M/s. Kiran J. Mehta & Co. for FY2025-26, and appointment of M/s. Nishant Pandya & Associates as Secretarial Auditors for a 5-year term covering FY2025-26 to FY2029-30. A special resolution seeks shareholder approval for continuation of 91-year-old Mr. Dinesh B. Patel as Non-Executive Director under SEBI LODR Regulation 17(1A). The record date for dividend eligibility is 19th September 2025, with e-voting open from 23rd to 25th September 2025.
For shareholders: The Rs. 1.50 per share dividend signals continued profitability and cash returns, though it's relatively modest on the Rs. 10 face value (15%). The 5-year secretarial auditor appointment and continuation of the 91-year-old Chairman as non-executive director are governance items unlikely to materially impact stock price. Shareholders should ensure KYC details and demat accounts are updated before 19th September 2025 to receive the dividend without higher TDS deduction.